Author

Kenneth N. Ross

Broad InstituteORCID 0000-0002-1723-8520Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1

Frequent Co-Authors

Gabriela AlexeiD· 2 shared Giulia DiGiovanniiD· 2 shared Kimberly StegmaieriD· 2 shared Alexander R. KovachiD· 1 shared Allen Thayakumar BasanthakumariD· 1 shared Ara JoiD· 1 shared Assil FahsiD· 1 shared Audrey TailloniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gabriela AlexeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer DiscoveryPeer-reviewedJul 14, 2026

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma

Susu Zhang, Kathleen L. Engel, Assil Fahs…·Kimberly Stegmaier

This study identifies CDK8 inhibition as a therapeutic strategy for alveolar rhabdomyosarcoma by inducing myogenic differentiation and impairing tumor growth through a mechanism involving the Mediator kinase module, SAGA complex, and SIX4.

DOI 10.1158/2159-8290.cd-25-1171

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 14, 2025

Rewiring the fusion oncoprotein EWS/FLI1 in Ewing sarcoma with bivalent small molecules

Michael J. Bond, Ryan P. Golden, Giulia DiGiovanni…·Kimberly Stegmaier

This study develops a bivalent small molecule, EB-TCIP, that relocalizes EWS/FLI1 to induce BCL6 target genes, demonstrating a strategy to target fusion oncoproteins in Ewing sarcoma.

1 citation

humanChIP-seq

𝕏 PostBluesky